The Lancet Global Health in conversation with

Clara Frick and Isabelle Soerjomataram on preventable and treatable deaths from 36 cancers worldwide


Listen Later

Fio Trethewey of The Lancet Global Health talks to Clara Frick and Dr Isabelle Soerjomataram about their research on premature cancer mortality which included a population-based study looking into preventable and treatable deaths from 36 cancers worldwide.

Read the full article:
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(23)00406-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langlo

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

...more
View all episodesView all episodes
Download on the App Store

The Lancet Global Health in conversation withBy The Lancet Group

  • 5
  • 5
  • 5
  • 5
  • 5

5

2 ratings


More shows like The Lancet Global Health in conversation with

View all
This American Life by This American Life

This American Life

91,010 Listeners

Radiolab by WNYC Studios

Radiolab

43,842 Listeners

Wait Wait... Don't Tell Me! by NPR

Wait Wait... Don't Tell Me!

38,900 Listeners

Fareed Zakaria GPS by CNN Podcasts

Fareed Zakaria GPS

3,434 Listeners

NEJM This Week by NEJM Group

NEJM This Week

325 Listeners

JAMA Clinical Reviews by JAMA Network

JAMA Clinical Reviews

497 Listeners

Diabetes Core Update by American Diabetes Association

Diabetes Core Update

101 Listeners

The Lancet Voice by The Lancet Group

The Lancet Voice

21 Listeners

The Lancet Child & Adolescent Health in conversation with by The Lancet Group

The Lancet Child & Adolescent Health in conversation with

0 Listeners

The Lancet Digital Health in conversation with by The Lancet Group

The Lancet Digital Health in conversation with

0 Listeners

The Lancet Oncology in conversation with by The Lancet Group

The Lancet Oncology in conversation with

1 Listeners

The Lancet Psychiatry in conversation with by The Lancet Group

The Lancet Psychiatry in conversation with

0 Listeners

The Lancet Respiratory Medicine in conversation with by The Lancet Group

The Lancet Respiratory Medicine in conversation with

2 Listeners

The Lancet in conversation with by The Lancet Group

The Lancet in conversation with

0 Listeners

Huberman Lab by Scicomm Media

Huberman Lab

29,142 Listeners

The Lancet Haematology in conversation with by The Lancet Group

The Lancet Haematology in conversation with

0 Listeners

The Lancet Gastroenterology & Hepatology in conversation with by The Lancet Group

The Lancet Gastroenterology & Hepatology in conversation with

0 Listeners

The Lancet Diabetes & Endocrinology in conversation with by The Lancet Group

The Lancet Diabetes & Endocrinology in conversation with

1 Listeners

The Lancet Infectious Diseases in conversation with by The Lancet Group

The Lancet Infectious Diseases in conversation with

0 Listeners

The Lancet Public Health in conversation with by The Lancet Group

The Lancet Public Health in conversation with

1 Listeners

The Lancet Microbe in conversation with by The Lancet Group

The Lancet Microbe in conversation with

0 Listeners

eBioMedicine in conversation with by The Lancet Group

eBioMedicine in conversation with

0 Listeners

In conversation with... by The Lancet Neurology

In conversation with...

0 Listeners

The Global Story by BBC World Service

The Global Story

271 Listeners

The Lancet Rheumatology in conversation with by The Lancet Group

The Lancet Rheumatology in conversation with

0 Listeners

The Lancet Regional Health in conversation with by The Lancet Group

The Lancet Regional Health in conversation with

0 Listeners

Good Hang with Amy Poehler by The Ringer

Good Hang with Amy Poehler

10,437 Listeners

The Lancet Primary Care in conversation with by The Lancet Group

The Lancet Primary Care in conversation with

0 Listeners

The Lancet Regional Health Americas in conversation with by The Lancet Group

The Lancet Regional Health Americas in conversation with

0 Listeners